Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis
Abstract Inconsistent reporting of clinical trials is well-known in the literature. Despite this, factors associated with poor practice such as outcome switching in clinical trials are poorly understood. We performed a cross-sectional analysis to evaluate the prevalence of, and the factors associate...
Guardado en:
Autores principales: | Alberto Falk Delgado, Anna Falk Delgado |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7af1641f304948d4923b46e71ded6888 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov
por: Kentaro Sakamaki, et al.
Publicado: (2021) -
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study
por: Alexandre Loupy, et al.
Publicado: (2021) -
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
por: María Gion, et al.
Publicado: (2021) -
Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov
por: Julia Lai‐Kwon, et al.
Publicado: (2021) -
Increasing Warmth in Oncological Patients: A Randomized Controlled Cross-Over Pilot Trial Examining the Efficacy of Mustard and Ginger Footbaths
por: Jan Vagedes MD, MA, et al.
Publicado: (2021)